Skip to content

Author

S. van den Hof

We have 5 of 253 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Post-pandemic SARS-CoV-2 infection incidence: a Dutch prospective seroepidemiological cohort study

Abstract   After the acute phase of the COVID-19 pandemic, surveillance was reduced and serological monitoring became crucial to monitor SARS-CoV-2 infections. We estimated infection incidence in the Netherlands during 2023–2024 using repeated serological sampling. We used data from randomly-selected Dutch citizens age...

Cce Van Hagen, Era Vos, H. de Melker et al. · 0 citations
Open access Sep 2026

Tuberculosis disease and infection screening among migrants in the Netherlands 2019–2023: a national retrospective observational study

Summary Background Migrants from tuberculosis (TB) high-incidence countries are at increased risk of TB, therefore, screening for TB is frequently implemented in host countries, but evidence for systematic screening for TB infection (TBI) is limited. We evaluated the national migrant TB/TBI screening programme in the N...

G. de Vries, A. Mulder, I. Spruijt et al. · 0 citations
Open access Oct 2026

Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake, the Netherlands, 2016 to 2025

BACKGROUND The Netherlands has experienced a decline in routine childhood vaccination uptake during and after the COVID-19 pandemic, with emerging evidence of reduced parental vaccine confidence. AIM To evaluate the immediate and long-term impact of the COVID-19 pandemic on first-dose diphtheria-tetanus-pertussis-polio...

J. Pijpers, M. Haverkate, R. van Gaalen et al. · 0 citations
Open access Aug 2026

Association between post-vaccination adverse events and subsequent COVID-19 booster uptake in the Netherlands.

A lower likelihood of subsequent COVID-19 booster uptake after experiencing systemic AE, particularly when severe or prolonged, or when experiencing a severe local AE is found, underscore the need to address experienced AE in communication strategies, as this may influence the success of vaccination campaigns.

Anne J. Huiberts, Maud M J Smits, C. Hoeve et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.